Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CITRESPLINE and CITRELOCK ACL Implants

K-Number: K210239 · 2021-02-24

Decision Date2021-02-24
Product CodeMAI
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

CITRESPLINE and CITRELOCK ACL Implants is a medical device manufactured by Acuitive Technologies, Inc.. It received FDA 510(k) clearance on 2021-02-24 under approval number K210239. The device is classified under product code MAI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CITRESPLINE and CITRELOCK ACL Implants?

CITRESPLINE and CITRELOCK ACL Implants is a medical device that received FDA 510(k) clearance on 2021-02-24. It is manufactured by Acuitive Technologies, Inc.. The 510(k) number is K210239.

When was CITRESPLINE and CITRELOCK ACL Implants approved by the FDA?

CITRESPLINE and CITRELOCK ACL Implants received FDA 510(k) clearance on 2021-02-24, under approval number K210239.

What company makes CITRESPLINE and CITRELOCK ACL Implants?

CITRESPLINE and CITRELOCK ACL Implants is manufactured by Acuitive Technologies, Inc..

What is the FDA product code for CITRESPLINE and CITRELOCK ACL Implants?

The FDA product code for CITRESPLINE and CITRELOCK ACL Implants is MAI.

Other Devices by Acuitive Technologies, Inc.

Related Devices (Code: MAI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.